|
Originally published In Press as doi:10.1074/jbc.C700171200 on December 6, 2007
J. Biol. Chem., Vol. 283, Issue 8, 4464-4468, February 22, 2008
Epac, in Synergy with cAMP-dependent Protein Kinase (PKA), Is Required for cAMP-mediated Mitogenesis*
Daniel Hochbaum,
Kyoungja Hong,
Guillermo Barila,
Fernando Ribeiro-Neto, and
Daniel L. Altschuler1
From the
Department of Pharmacology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261
cAMP stimulates proliferation in many cell types. For many years, cAMP-dependent protein kinase (PKA) represented the only known cAMP effector. PKA, however, does not fully mimic the action of cAMP, indicating the existence of a PKA-independent component. Since cAMP-mediated activation of the G-protein Rap1 and its phosphorylation by PKA are strictly required for the effects of cAMP on mitogenesis, we hypothesized that the Rap1 activator Epac might represent the PKA-independent factor. Here we report that Epac acts synergistically with PKA in cAMP-mediated mitogenesis. We have generated a new dominant negative Epac mutant that revealed that activation of Epac is required for thyroid-stimulating hormone or cAMP stimulation of DNA synthesis. We demonstrate that Epac's action on cAMP-mediated activation of Rap1 and cAMP-mediated mitogenesis depends on the subcellular localization of Epac via its DEP domain. Disruption of the DEP-dependent subcellular targeting of Epac abolished cAMP-Epac-mediated Rap1 activation and thyroid-stimulating hormone-mediated cell proliferation, indicating that an Epac-Rap-PKA signaling unit is critical for the mitogenic action of cAMP.
Received for publication, August 22, 2007
, and in revised form, November 13, 2007.
* This work was supported by Public Health Service grant CA071649 from the National Cancer Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains a supplemental figure.
1 To whom correspondence should be addressed: Dept. of Pharmacology, School of Medicine, University of Pittsburgh, 200 Lothrop St, W1316 BSTWR, Pittsburgh, PA 15261. Tel.: 412-648-9751; Fax: 412-648-1945; E-mail: altschul{at}pitt.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Ponsioen, M. Gloerich, L. Ritsma, H. Rehmann, J. L. Bos, and K. Jalink
Direct Spatial Control of Epac1 by Cyclic AMP
Mol. Cell. Biol.,
May 15, 2009;
29(10):
2521 - 2531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Huang, S. H. Wettlaufer, J. Chung, and M. Peters-Golden
Prostaglandin E2 Inhibits Specific Lung Fibroblast Functions via Selective Actions of PKA and Epac-1
Am. J. Respir. Cell Mol. Biol.,
October 1, 2008;
39(4):
482 - 489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hong, L. Lou, S. Gupta, F. Ribeiro-Neto, and D. L. Altschuler
A Novel Epac-Rap-PP2A Signaling Module Controls cAMP-dependent Akt Regulation
J. Biol. Chem.,
August 22, 2008;
283(34):
23129 - 23138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Yokoyama, H. H. Patel, N. C. Lai, N. Aroonsakool, D. M. Roth, and P. A. Insel
The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals
PNAS,
April 29, 2008;
105(17):
6386 - 6391.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|